2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Patients with mitral valve prolapse (MVP) have high risk of life-threatening ventricular arrhythmias (VAs). Data on the impact of exercise on arrhythmic risk in these patients are lacking. We explored whether lifetime exercise dose was associated with severe VA and with established risk factors in patients with MVP. Furthermore, we explored the circumstances at the VA event.

          Methods and results

          In this retrospective cohort study, we included patients with MVP and assessed lifetime exercise dose as metabolic equivalents of task (MET) hours/week. Severe VA was defined as sustained ventricular tachycardia or fibrillation, aborted cardiac arrest, and appropriate shock by a primary preventive implantable cardioverter defibrillator. We included 136 MVP patients (48 years [interquartile range (IQR) 35–59], 61% female), and 17 (13%) had previous severe VA. The lifetime exercise dose did not differ in patients with and without severe VA (17 MET h/week [IQR 9–27] vs. 14 MET h/week [IQR 6–31], P = 0.34). Lifetime exercise dose > 9.6 MET h/week was a borderline significant marker for severe VA (OR 3.38, 95% CI 0.92–12.40, P = 0.07), while not when adjusted for age (OR 2.63, 95% CI 0.66–10.56, P = 0.17). Ventricular arrhythmia events occurred most frequently during wakeful rest (53%), followed by exercise (29%) and sleep (12%).

          Conclusion

          We found no clear association between moderate lifetime exercise dose and severe VA in patients with MVP. We cannot exclude an upper threshold for safe levels of exercise. Further studies are needed to explore exercise and risk of severe VA.

          Graphical Abstract

          Graphical Abstract

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Health benefits of physical activity: a systematic review of current systematic reviews.

          The health benefits of physical activity and exercise are clear; virtually everyone can benefit from becoming more physically active. Most international guidelines recommend a goal of 150 min/week of moderate-to-vigorous intensity physical activity. Many agencies have translated these recommendations to indicate that this volume of activity is the minimum required for health benefits. However, recent evidence has challenged this threshold-centered messaging as it may not be evidence-based and may create an unnecessary barrier to those who might benefit greatly from simply becoming more active. This systematic review evaluates recent systematic reviews that have examined the relationship between physical activity and health status.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The pandemic of physical inactivity: global action for public health.

            Physical inactivity is the fourth leading cause of death worldwide. We summarise present global efforts to counteract this problem and point the way forward to address the pandemic of physical inactivity. Although evidence for the benefits of physical activity for health has been available since the 1950s, promotion to improve the health of populations has lagged in relation to the available evidence and has only recently developed an identifiable infrastructure, including efforts in planning, policy, leadership and advocacy, workforce training and development, and monitoring and surveillance. The reasons for this late start are myriad, multifactorial, and complex. This infrastructure should continue to be formed, intersectoral approaches are essential to advance, and advocacy remains a key pillar. Although there is a need to build global capacity based on the present foundations, a systems approach that focuses on populations and the complex interactions among the correlates of physical inactivity, rather than solely a behavioural science approach focusing on individuals, is the way forward to increase physical activity worldwide.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

                Bookmark

                Author and article information

                Contributors
                Journal
                Europace
                Europace
                europace
                Europace
                Oxford University Press (US )
                1099-5129
                1532-2092
                October 2023
                18 October 2023
                18 October 2023
                : 25
                : 10
                : euad309
                Affiliations
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Department of Cardiology, ProCardio Center for Innovation, Oslo University Hospital, Rikshospitalet , PO Box 4950 Nydalen, 0424 Oslo, Norway
                Faculty of Medicine, Institute of Clinical Medicine, University of Oslo , PO Box 1078 Blindern, 0316 Oslo, Norway
                Author notes
                Corresponding author. Tel: +47 92833646, E-mail address: kristina.haugaa@ 123456medisin.uio.no

                Conflict of interest: None declared.

                Author information
                https://orcid.org/0000-0002-2376-0884
                https://orcid.org/0000-0003-2056-2441
                https://orcid.org/0000-0001-9466-856X
                https://orcid.org/0000-0003-1434-8932
                https://orcid.org/0000-0003-1663-1117
                https://orcid.org/0000-0002-4312-9969
                https://orcid.org/0000-0002-2022-4568
                https://orcid.org/0000-0002-4900-0453
                Article
                euad309
                10.1093/europace/euad309
                10616587
                37851515
                e3ab7f74-6292-4e4d-b7ad-0b741481f83b
                © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 14 August 2023
                : 11 October 2023
                Page count
                Pages: 9
                Funding
                Funded by: Norwegian Research council, ProCardio;
                Funded by: GENE POSITIVE;
                Funded by: EMPATHY;
                Categories
                Clinical Research
                AcademicSubjects/MED00200
                Eurheartj/45
                Eurheartj/46
                Eurheartj/48
                Eurheartj/55

                Cardiovascular Medicine
                exercise,mitral valve prolapse,mitral annular disjunction,sudden cardiac death,high intensity exercise

                Comments

                Comment on this article